This report presents the results of the first monitoring round of the implementation of the MEDICRIME Convention, focusing on the protection of public health through the MEDICRIME Convention in times of pandemics.

Covering 13 Parties, the executive summary highlights key findings on prevention strategies, gaps in training and education, victim protection systems, inter-agency and cross-border cooperation, detection mechanisms, investigation and prosecution, sanctions, and the critical lack of robust data collection. Despite well-developed regulatory frameworks, persistent weaknesses were identified, including inconsistent training, insufficient civil society engagement, fragmented victim support and vulnerabilities in market surveillance, particularly exposed during COVID-19. The report urges coordinated legislative, operational and data-sharing improvements, enhanced awareness-raising campaigns and the institutionalisation of multi-sectoral cooperation involving regulatory authorities, customs, police, judiciary, health care professionals, industry, and civil society. Against this background, Cooperation between all relevant stakeholders, and civil society, is essential to ensure that effective measures against the counterfeiting of medical products and similar crimes involving threats to public health are enacted and implemented.